Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Altius Bioventures Capital is a venture capital firm founded to create and launch early-stage companies focused on advanced therapy technologies. Established in North Vancouver, Canada, the firm aims to transform the advanced therapy space, making treatments more affordable and accessible globally. Altius Bioventures operates primarily within North America, targeting the biotech and healthcare sectors.
The firm emphasizes strategic support alongside financial investment, aiming to enhance the development of scalable tools and technologies in the advanced therapy sector. Altius Bioventures has a dedicated team of founding partners and strategic advisors with extensive expertise in investment and advanced therapies.
Altius Bioventures invests in early-stage companies that develop scalable tools and technologies in the advanced therapy sector, particularly in cell and gene therapy (CGT). Their investment strategy includes forming Special Purpose Vehicles (SPVs) for targeted investments, which allows them to provide strategic support tailored to each company's needs. The firm focuses on pre-seed, seed, and seed-plus stages, ensuring that they align closely with founders from the outset.
Investment decisions are driven by the potential for innovation in the biotech and healthcare sectors. Altius Bioventures seeks to partner with companies that demonstrate a commitment to transforming the advanced therapy landscape, enhancing global accessibility to treatments. Their emphasis on early commitment ensures that they are aligned with the vision and goals of the founders they support.
Altius Bioventures has not publicly disclosed specific portfolio companies. However, their investment focus on early-stage companies in the advanced therapy sector suggests a commitment to supporting innovative startups in cell and gene therapy. The firm’s strategy of forming Special Purpose Vehicles (SPVs) indicates a tailored approach to investment, allowing them to concentrate on specific opportunities within the biotech and healthcare sectors.
While specific outcomes or notable exits are not mentioned, the firm’s emphasis on strategic support alongside financial investment positions them as a valuable partner for startups aiming to develop scalable technologies in advanced therapies.
Emmanuel Grillot - Founding Partner, Managing Director. Emmanuel has extensive experience in investment and advanced therapies, leading various initiatives in the biotech sector.
Lee Buckler - Founding Partner, Sourcing Team. Lee specializes in identifying promising early-stage companies and has a strong background in healthcare investments.
Troels Jordansen - Founding Partner, Investment Team. Troels brings expertise in investment strategies and portfolio management, focusing on biotech innovations.
Troels Jordansen - Founding Partner, Portfolio Team. Troels is involved in managing portfolio companies and ensuring alignment with investment goals.
Shinichi Muto - Investment Committee, Strategic Advisor. Shinichi provides insights into market trends and investment opportunities in advanced therapies.
Chaminda Salgado - Investment Committee, Strategic Advisor. Chaminda has a strong background in biotech investments and strategic planning.
Bryan Poltilove - Investment Committee, Strategic Advisor. Bryan offers expertise in operational support and scaling biotech companies.
Jason C. Foster - Investment Committee, Strategic Advisor. Jason contributes to investment decisions with a focus on market viability and growth potential.
Arnaud Deladeriere - Strategic Advisor. Arnaud provides strategic insights and guidance to portfolio companies.
Founders can pitch to Altius Bioventures through their website. It is recommended to include a detailed deck that outlines the technology, market potential, and team background. A warm introduction may enhance the chances of a favorable response, although it is not strictly required.
What are Altius Bioventures' investment criteria?
Altius Bioventures focuses on early-stage companies in the biotech and healthcare sectors, particularly those developing scalable tools and technologies in advanced therapies, including cell and gene therapy.
How can I pitch to Altius Bioventures?
Founders can pitch their ideas through the firm’s website at altiusbioventures.vc. It is advisable to include a clear outline of the technology, market potential, and team background in the pitch.
What makes Altius Bioventures different from other investors?
Altius Bioventures emphasizes early commitment and alignment with founders, forming Special Purpose Vehicles (SPVs) for targeted investments, which allows for tailored strategic support.
What is the geographic scope of Altius Bioventures?
The firm primarily operates within North America, focusing on early-stage investments in the biotech and healthcare sectors.
What is the typical check size for investments?
While specific check sizes are not disclosed, Altius Bioventures focuses on pre-seed, seed, and seed-plus stages, indicating a range that aligns with early-stage funding needs.
What kind of post-investment involvement can founders expect?
Altius Bioventures provides strategic support alongside financial investment, which may include mentorship, operational support, and assistance in scaling the business.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.